Author:
Fukahori Michiko,Kimura Naoko,Miyauchi Yoshihiro,Hirano Kazuhiko,Morimoto Kohei,Takahashi Miyuki,Ueda Ayaka,Okazaki Sayano,Taguchi Keisuke,Tsukahara Yu,Hattori Sakurako,Suematsu Yuki,Yan Masahiro,Teranishi Nobuhisa,Wakabayashi Kazuhiko,Itoh Yutaka
Abstract
Abstract
Background
Ectopic thymomas often occur in the upper mediastinum; however, they rarely arise in the middle mediastinum, especially on the dorsal side of the innominate vein and superior vena cava in the peribronchial region.
Case presentation
Six years prior, a 27-year-old female presented to our department and was diagnosed with locally advanced left breast cancer. First, we administered chemotherapy including an anti-human epidermal growth factor receptor 2 antibody. The size of the tumor was markedly reduced, and a radical operation involving mastectomy and axillary lymph node dissection was then performed. The patient underwent radiotherapy after the mastectomy, followed by trastuzumab therapy; she continued to receive endocrine therapy thereafter. She underwent computed tomography once a year after the surgery, and a nodule in the middle mediastinum on the dorsal side of the innominate vein and superior vena cava in the parabronchial region was detected at 4 years. We speculated that the nodule was a solitary mediastinal lymph node metastasis from her breast cancer; therefore, we performed thoracoscopic resection of the tumor. We diagnosed the tumor as a thymoma. Currently, the patient visits our hospital to receive continuous hormone therapy for her breast cancer, and the latest computed tomography scan demonstrated no metastases from or recurrence of her breast cancer or thymoma.
Conclusions
We report a case of ectopic thymoma in the middle mediastinum. The tumor, which was detected during systemic therapy for locally advanced breast cancer, was located on the dorsal side of the innominate vein and superior vena cava in the parabronchial region and was indistinguishable from a lymph node metastasis from breast cancer.
Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Travis WD, Brambilla E, Burke AP, et al. World health organization classification of tumours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2015.
2. Masaoka A, Monden Y, Nakahara K, et al. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981;48(11):2485–92.
3. Brierley JD, Gospodarowicz MK, Wikkekind C (eds). Union for International Cancer Control (UICC) TNM classification of malignant tumors 8th ed. Wiley-Blackwell, 2017.
4. Hsu CH, Chan JK, Yin CH, et al. Trends in the incidence of thymoma, thymic carcinoma, and thymic neuroendocrine tumor in the United States. PLoS ONE. 2019;14(12):0227197.
5. Ishibashi M, Tanabe Y, Yunaga H, et al. Usefulness of preoperative (18)F-FDG PET/CT for patients with thymic epithelial tumors. Yonago Acta Med. 2019;62(1):146–52.